|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Other current assets | |||||||||||||||||||
| Investments in available-for-sale securities | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| SAFE note subscription receivable | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Long-term prepaid expenses | |||||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||||
| Long-term prepaid expenses and other non-current assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||||||
| Note payable - stockholder | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses | |||||||||||||||||||
| Operating lease liabilities - current | |||||||||||||||||||
| Accrued compensation | |||||||||||||||||||
| RSU liability award | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| SAFE notes | |||||||||||||||||||
| Operating lease liabilities - non-current | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders' equity (deficit) | |||||||||||||||||||
| Common stock, par value $0.0001 and $0.0001 per share, 300,000,000 shares authorized, 59,779,233 and 51,099,089 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||||||
| Total stockholders' equity | |||||||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||||||
Loading...